Exploitation of biotechnology in a large company

Almost from the outset, most large companies saw the 'new biotechnology' not as a new business but as a set of very powerful techniques that, in time, would radically improve the understanding of biological systems. This new knowledge was generally seen by them as enhancing the process of invention and not as a substitute for tried and tested ways of meeting clearly identified targets. As the knowledge base grows, so the big-company response to biotechnology becomes more positive. Within ICI, biotechnology is now integrated into five bio-businesses (Pharmaceuticals, Agrochemicals, Seeds, Diagnostics and Biological Products). Within the Central Toxicology Laboratory it also contributes to the understanding of the mechanisms of toxic action of chemicals as part of assessing risk. ICI has entered two of these businesses (Seeds and Diagnostics) because it sees biotechnology making a major contribution to the profitability of each.     

Guidelines for establishing a culture collection within a biotechnology company

Culture collections within large pharmaceutical and biological companies act as depositories for preserving and maintaining important strains owned by, on the premises of, or sought on behalf of, the company. Other functions of a culture collection include: (a) regulating the flow of cultures into and out of the company; (b) recording and documenting such transfers; and (c) characterizing and/or identifying strains used for research, publications and patents. A culture collection within a biotechnology company is often required to maintain a diverse group of both prokaryote and eukaryote recombinant and non-recombinant strains. All strains and plasmids must be carefully characterized and preserved. A microbiologist with a strong background in microbial physiology, genetics and taxonomy is usually responsible for supervising the culture collection. This article focuses on guidelines for establishing a culture collection in biotechnology companies to serve the needs of both the scientist and the company.     

In search of genohype: A content analysis of biotechnology company documents

A symbology of power is assigned to DNA and genetics both in the media and in scientific publications. The term 'genohype' was offered by Holtzman (Are genetic tests adequately regulated? Science , 286 (4539), pp. 409-410, 1999) to characterize the discourse of exaggerated claims and hyperbole attached to DNA and the effort to map the human genome. In this paper, I examine the relationship between language and ideology in a systematic search for 'genohype' in biotechnology industry investor handbooks and annual reports. Three forms for 'genohype' are identified and one of these - 'possessing nature' - is isolated as involving the making of medicine. Using the NVivo software, a search of finance-related and health-related keywords showed that 'genohype' is basically not present in this investor material. The results are interpreted as reflecting the separate domains of financial capital and intellectual capital that are the ideological theatres for the production of medical commodities.     

Microfluidics in biotechnology

Microfluidics enables biotechnological processes to proceed on a scale (microns) at which physical processes such as osmotic movement, electrophoretic-motility and surface interactions become enhanced. At the microscale sample volumes and assay times are reduced, and procedural costs are lowered. The versatility of microfluidic devices allows interfacing with current methods and technologies. Microfluidics has been applied to DNA analysis methods and shown to accelerate DNA microarray assay hybridisation times. The linking of microfluidics to protein analysis techologies, e.g. mass spectrometry, enables picomole amounts of peptide to be analysed within a controlled micro-environment. The flexibility of microfluidics will facilitate its exploitation in assay development across multiple biotechnological disciplines.     

Perfluorochemicals in biotechnology

Gas transport often is a limiting factor in biotechnology. Perfluorochemicals provide a new vehicle for the transport of gases.     

多拷贝策略在小肽表达中的应用

基因工程技术已经在大分子多肽表达上得到了广泛的应用。但是小分子多肽不稳定且易降解,使其表达后很难检测和纯化。多拷贝策略是将目的基因或是含有目的基因的表达盒首尾串联,而串联构建多拷贝表达载体是目前解决小分子多肽表达量少的有效方法。总结和比较非对称粘性末端互补法、接头连接法、同尾酶法和表达盒串联法在多肽表达方面的应用情况,为小分子多肽的体外表达提供方法和思路。     

Microbial processing of tellurium as a tool in biotechnology

Here, we overview the most recent advances in understanding the bacterial mechanisms that stay behind the reduction of tellurium oxyanions in both planktonic cells and biofilms. This is a topic of interest for basic and applied research because microorganisms are deeply involved in the transformation of metals and metalloids in the environment. In particular, the recent observation that toxic tellurite can be precipitated either inside or outside the cells being used as electron sink to support bacterial growth, opens new perspectives for both microbial physiologists and biotechnologists. As promising nanomaterials, tellurium based nanoparticles show unique electronic and optical properties due to quantum confinement effects to be used in the area of chemistry, electronics, medicine and environmental biotechnologies.     

Proteinase inhibitors in plant biotechnology: a review

Possible utilities for natural inhibitors of proteolytic enzymes in plant biotechnology have been reviewed. Among the potential areas of use of the inhibitors are (1) construction of transgenic plants with increased resistance to insects and other pests and (2) development of procedures for biosynthesis of recombinant proteins. In the latter case, the inhibitors will serve to prevent the protein degradation by proteinases.     

Marine biotechnology in education: a competitive approach

This paper describes the development of a practical, which is taught to third year biotechnology students. We wanted to motivate the students by making them responsible for a research project. Competition was added as a stimulus for interaction between the students. A virtual company called CaroTech employed the students for 2 weeks. They worked in groups of two persons and each group was responsible for a 0.8 l flat panel photobioreactor. They had to produce as much beta-carotene as possible using the marine alga strain Dunaliella salina in this photobioreactor. On the first day, students developed a strategy to obtain optimal algal growth rate. They putted this plan into practice the second day and while cultivating the organism, they developed a second strategy how and when to stress the alga to initiate beta-carotene production. At the end of the ninth day, the total amount of beta-carotene was measured. To stimulate competition, the group that produced the most beta-carotene obtained half a point bonus on the final practical mark. On the tenth day, each group presented their results and an evaluation of their chosen strategies to the CaroTech board. Most groups were successful in growing algae. In the second phase some groups failed to stress the alga. The best group produced more than two times beta-carotene than the runner-up. The students were motivated by being responsible for their own results and the competitive approach. All students liked the practical and indicated that they learned a lot by following this practical.